MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/nu17050820

Медицинская библиотека · Nutrients · 2025

Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?

Novella-Navarro Marta, Van Den Rym Ana, López-Pedrera Chary, Martínez-Feito Ana, Nieto-Carvalhal Beatriz, Reche Keren, López-Medina Clementina, Escudero-Contreras Alejandro, Nozal Pilar, Miranda-Carús Maria Eugenia, Monjo Irene, De Miguel Eugenio, Balsa Alejandro, Pérez-De Diego Rebeca, Plasencia-Rodríguez Chamaida

СтатьяПеревод в очереди

Аннотация

Background

Obesity is a frequent comorbidity in rheumatoid arthritis (RA). This condition may lead these patients to have poorer disease control and a worse response to some of the available treatments.

Objectives

We aim to analyze the role of body mass index (BMI) in the clinical response to Janus kinase inhibitors (JAKis) in patients with RA. We aim to perform an in-depth analysis of the pathophysiology of obesity by assessing serum adipokine levels, their potential influence in disease activity and their changes with treatment.

Methods

This study involved 81 patients with RA treated with JAKis from Hospital La Paz and Hospital Reina Sofía. Patients were classified according to their BMI as normal weight and overweight/obesity. The clinical response to treatment was assessed by the Clinical Disease Activity Index (CDAI) and Disease Activity Score-28 (DAS28) 6 months after the initiation of JAKis. Serum adipokines (leptin and adiponectin) were determined using a commercial immunoassay kit in samples obtained before the initiation of JAKis and after 6 months of treatment.

Results

Leptin levels showed a significant positive correlation with BMI at baseline (r = 0.59, p < 0.01) and at 6 months (r = 0.56, p < 0.01) in the whole cohort, but no correlation was found between BMI and adiponectin. No correlation between disease activity and BMI was found in the whole cohort at baseline and at 6 months measured by both the CDAI and DAS28. Fifty patients (61.7%) achieved low disease activity (LDA)/remission at 6 months, regardless their BMI, and no differences in serum adipokine levels were observed at baseline and at 6 months in patients who achieved LDA vs. no-LDA.

Conclusions

In this study, we did not find an association between obesity and the extent of LDA in patients treated with JAKis; therefore, this mechanism of action could be suitable for overweight/obese patients with RA.

Для цитирования: Novella-Navarro Marta, Van Den Rym Ana, López-Pedrera Chary, Martínez-Feito Ana, Nieto-Carvalhal Beatriz, Reche Keren, López-Medina Clementina, Escudero-Contreras Alejandro, Nozal Pilar, Miranda-Carús Maria Eugenia, Monjo Irene, De Miguel Eugenio, Balsa Alejandro, Pérez-De Diego Rebeca, Plasencia-Rodríguez Chamaida. Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?. Nutrients. 2025. DOI: 10.3390/nu17050820.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.